Reporting owner · CIK 0001835966
Sandler Alan B.
SEC Form 4 history across 1 companies, 9 transactions and 2 filings.
CDOChief Development OfficerRevolution Medicines, Inc.
Open-market transaction mix0% buys0 buys · 7 sales
Available history · Sep 16, 2026 – Sep 29, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$61.6kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$244kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$202kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$324kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$441kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | M · exercise10b5-1 detectedSEC filing ↗ | $353kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$66.9kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$975View disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Revolution Medicines, Inc. on Sep 29, 2026 valued at $61,621.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 1 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Sep 2026 | 0 | 7 | $0.00 | $1,343,234.90 | -$1,343,234.90 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$191.9K
Median P/S size$202.8K
Direct9
Indirect0
Sep 29, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
8 observations · Sep 16, 2026 – Sep 29, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 29, 202652,559 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Sep 16, 2026 | 53,204 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 52,868 | Sep 18, 2026 | View transaction |
| Sep 29, 2026 | 58,868 | Oct 1, 2026 | View transaction |
| Sep 29, 2026 | 56,668 | Oct 1, 2026 | View transaction |
| Sep 29, 2026 | 55,059 | Oct 1, 2026 | View transaction |
| Sep 29, 2026 | 54,059 | Oct 1, 2026 | View transaction |
| Sep 29, 2026 | 52,860 | Oct 1, 2026 | View transaction |
| Sep 29, 2026 | 52,559 | Oct 1, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Sandler Alan B. Insider Activity FAQ
SEC Form 4 context
Who is Sandler Alan B.?
Sandler Alan B. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001835966.
Which companies has Sandler Alan B. reported transactions for?
Revolution Medicines, Inc., ALX ONCOLOGY HOLDINGS INC, Mirati Therapeutics, Inc.
When was Sandler Alan B.'s latest insider buy?
No open-market insider purchase is available for this period.
When was Sandler Alan B.'s latest insider sale?
sale at Revolution Medicines, Inc. on Sep 29, 2026 valued at $61,621.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.